Print

Global: To establish harmonised assays of known performance across multiple laboratories for the assessment of immunological responses to candidate Shigella vaccines in clinical trials
Details
Locations:Israel
Start Date:Jul, 2022
End Date:Nov, 2026
Contract value: USD 60,000
Sectors: Health, Research & Innovation
Description
Purpose: To establish harmonised assays of known performance across multiple laboratories for the assessment of immunological responses to candidate Shigella vaccines in clinical trials
Division: Global Health
Region served: GLOBAL
Grant topic: Enterics, Diagnostics, Genomics & Epidemiology
Duration (months): 52
Grantee location: Tel Aviv, Israel
